Memory problems and dementia assessment
Forgetfulness has many causes, and most of them are not dementia: lack of sleep, stress, depression, medication, thyroid or vitamin deficiencies all affect memory and concentration. A thorough assessment finds treatable causes – and, if early dementia is present after all, provides clarity and time for decisions.
The core of the assessment is standardised neuropsychological testing, which we carry out in the practice ourselves, complemented by a neurological examination, EEG and – via our network of cooperating neuroradiologists – imaging.
Typical reasons to come
- Increasing forgetfulness in daily life, word-finding problems, difficulties with appointments or finances
- Relatives notice changes that the person is less aware of
- Concentration problems after an illness, with fatigue or under medication
- A wish for a baseline measurement where there is a family history
What we do
| Consultation | History, where possible with a trusted person, medication list, sleep and mood; neurological examination. |
|---|---|
| Testing | Standardised neuropsychological test battery (e.g. CERAD-Plus, MoCA, computer-based tests) with a written report and age-related interpretation; follow-up measurement after 6 to 12 months. |
| Instrument-based diagnostics | EEG; MRI of the head via cooperating neuroradiologists; laboratory values in coordination with your GP. Where needed we refer for cerebrospinal fluid or PET diagnostics at specialised centres. |
| Interpretation and plan | Discussion of results, treatment of treatable causes, therapy according to the S3 guideline, advice on daily life, driving and advance planning; contact to counselling services and relatives’ groups. |
What the evidence says
The German S3 guideline on dementia (DGN/DGPPN) recommends a structured assessment of memory complaints with neuropsychological testing, laboratory tests and imaging; biomarkers from cerebrospinal fluid or PET confirm the diagnosis where this has consequences. Since 2025 the first antibody therapies against Alzheimer’s disease are approved in the EU for a narrowly defined group of patients; eligibility is assessed at specialised centres to which we refer.
Non-invasive brain stimulation for mild cognitive impairment or Alzheimer’s dementia is being researched; the evidence is inconsistent and there is no guideline recommendation. We do not currently offer it as a treatment.
Procedure, duration, costs
Limits
Sudden confusion, especially with fever, after a fall or under new medication, is an emergency – call 112. Testing in the practice does not replace inpatient assessment in such situations.
Book an appointment +49 30 75633615
Related topics
This page provides general information and does not replace medical advice or an examination. Last updated: October 2026.
Next: Dizziness & vertigo